Articles by K. A. Dugi (2)

Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes

T. Forst, B. Uhlig-Laske, A. Ring, U. Graefe-Mody, C. Friedrich, K. Herbach, H.-J. Woerle and K. A. Dugi

Diabetic Medicine 27 ( 12 ): 1409 - 1419 , 2010

Efficacy and safety of linagliptin in persons with Type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study

D. R. Owens, R. Swallow, K. A. Dugi and H. J. Woerle

Diabetic Medicine 28 ( 11 ): 1352 - 1361 , 2011

Do you have a suggestion for journals

Suggest Journal